Genmab A/S Files 6-K, Incorporates Articles of Association
Ticker: GNMSF · Form: 6-K · Filed: Aug 13, 2025 · CIK: 1434265
| Field | Detail |
|---|---|
| Company | Genmab A/S (GNMSF) |
| Form Type | 6-K |
| Filed Date | Aug 13, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, filing-update
TL;DR
Genmab filed a 6-K with updated Articles of Association, now part of its S-8 filings.
AI Summary
Genmab A/S filed a Form 6-K on August 13, 2025, to report updates. This filing is incorporated by reference into several of Genmab's S-8 registration statements, including File Nos. 333-232693, 333-253519, 333-262970, 333-277273, and 333-284876. The primary exhibit listed is the company's Articles of Association.
Why It Matters
This filing ensures that Genmab's Articles of Association are officially part of its existing registration statements, providing updated governance information for investors.
Risk Assessment
Risk Level: low — This is a routine filing of corporate documents and does not introduce new financial or operational risks.
Key Players & Entities
- Genmab A/S (company) — Registrant
- 333-232693 (dollar_amount) — S-8 Registration Statement File Number
- 333-253519 (dollar_amount) — S-8 Registration Statement File Number
- 333-262970 (dollar_amount) — S-8 Registration Statement File Number
- 333-277273 (dollar_amount) — S-8 Registration Statement File Number
- 333-284876 (dollar_amount) — S-8 Registration Statement File Number
FAQ
What type of filing is this Form 6-K?
This is a Report of Foreign Private Issuer pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934.
What is the filing date for this report?
The filing date is August 13, 2025.
What is the primary purpose of this 6-K filing?
The filing is to incorporate by reference Genmab A/S's Articles of Association into its existing registration statements on Form S-8.
Which registration statements are affected by this filing?
The filing is incorporated into Genmab A/S's registration statements on Form S-8 with File Numbers 333-232693, 333-253519, 333-262970, 333-277273, and 333-284876.
What is the main exhibit included in this filing?
The main exhibit is the Articles of Association of Genmab A/S.
Filing Stats: 211 words · 1 min read · ~1 pages · Grade level 14.1 · Accepted 2025-08-13 10:35:56
Filing Documents
- gmab_20250813x6k.htm (6-K) — 13KB
- gmab_20250813ex3d1.htm (EX-3.1) — 215KB
- 0001434265-25-000068.txt ( ) — 229KB
From the Filing
Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE MONTH OF AUGUST 2025 COMMISSION FILE NUMBER 001-38976 Genmab AS (Exact name of Registrant as specified in its charter) Carl Jacobsens Vej 30 2500 Valby Denmark +45 70 20 27 28 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. Form 20-F Form 40-F This report on Form 6-K shall be deemed to be incorporated by reference in Genmab AS's registration statements on Form S-8 (File No. 333-232693, 333-253519, 333-262970, 333-277273 and 333-284876 ) and to be a part thereof from the date on which this report is filed, to the extent not superseded by documents or reports subsequently filed or furnished. EXHIBIT INDEX Exhibit Description of Exhibit 3.1 Articles of Association SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. GENMAB AS BY s Anthony Pagano Name Anthony Pagano Title Executive Vice President Chief Financial Officer DATE August 13, 2025